Mohammad Shoushtari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohammad Shoushtari has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ali Shojaeian
Hamadan University of Medical Sciences
1 shared publication Armin Khaghani Boroujeni
Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
1 shared publicationH. Madanchi
Department of Biotechnology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
1 shared publication- Hamed Haddad Kashani
Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
1 shared publication Hamid Madanchi
Department of Medical Biotechnology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
1 shared publicationIman Owliaee
Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
1 shared publication
Latest Publications
- 7 January 2025
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17 (4) , 2058-2085
Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions
This review delves into the potential of antimicrobial peptides (AMPs) as promising candidates for combating arboviruses, focusing on their mechanisms of antiviral activity, challenges, and future directions. AMPs have shown promise in preventing arbovirus attachment to host cells, inducing interferon production, and targeting multiple viral stages, illustrating their multifaceted impact on arbovirus infections. Structural elucidation of AMP–viral complexes is explored to deepen the understanding of molecular determinants governing viral neutralization, paving the way for structure-guided design. Furthermore, this review highlights the potential of AMP-based combination therapies to create synergistic effects that enhance overall treatment outcomes while minimizing the likelihood of resistance development. Challenges such as susceptibility to proteases, toxicity, and scalable production are discussed alongside strategies to address these limitations. Additionally, the expanding applications of AMPs as vaccine adjuvants and antiviral delivery systems are emphasized, underscoring their versatility beyond direct antiviral functions.
- 7 January 2025
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17 (4) , 2058-2085
Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions
This review delves into the potential of antimicrobial peptides (AMPs) as promising candidates for combating arboviruses, focusing on their mechanisms of antiviral activity, challenges, and future directions. AMPs have shown promise in preventing arbovirus attachment to host cells, inducing interferon production, and targeting multiple viral stages, illustrating their multifaceted impact on arbovirus infections. Structural elucidation of AMP–viral complexes is explored to deepen the understanding of molecular determinants governing viral neutralization, paving the way for structure-guided design. Furthermore, this review highlights the potential of AMP-based combination therapies to create synergistic effects that enhance overall treatment outcomes while minimizing the likelihood of resistance development. Challenges such as susceptibility to proteases, toxicity, and scalable production are discussed alongside strategies to address these limitations. Additionally, the expanding applications of AMPs as vaccine adjuvants and antiviral delivery systems are emphasized, underscoring their versatility beyond direct antiviral functions.
- Open Access
- 1 March 2020
- Published by Elsevier in New Microbes and New Infections
- Vol. 34, 100627
Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases
- 1 March 2020
- Published by Elsevier in New Microbes and New Infections
- Vol. 34, 100627
Open AccessAntimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases